Christopher A. Guerreiro
Norton Rose Fulbright Canada LLP
Related services and key industries
Christopher Guerreiro practises contentious intellectual property dispute resolution and litigation, with an emphasis on patents and issues affecting the life sciences, healthcare, and other high-technology industries. Mr. Guerreiro has particular experience with complex pharmaceutical and medical-device patent infringement and impeachment actions, as well as prohibition and damages proceedings under the Patented Medicines (Notice of Compliance) Regulations. He also advises on intellectual property-related regulatory structures affecting the life sciences industries, such as the Patented Medicine Prices Review Board.
Mr. Guerreiro brings a practical, business-focused approach to his practice, relying on over four years of pre-law experience in pharmaceutical clinical and commercial operations and his education in biology. During his articles, Mr. Guerreiro gained additional perspective on the commercial and regulatory dimensions of the innovative pharmaceutical industry while on secondment to the in-house legal team at GlaxoSmithKline.
While studying at Osgoode Hall Law School, Mr. Guerreiro was recognized for achieving top standing in areas including evidence, civil procedure, conflict of laws, business law, and contracts, and graduated second in his class. Mr. Guerreiro has continued his involvement with Osgoode as a member of the upper-year theory and practice of negotiation teaching team.
Mr. Guerreiro joined our Toronto office as a summer student in 2011 and returned as an articling student in 2012–2013.
- Ontario 2013
Mr. Guerreiro's litigation experience touches all stages of case development, pre-trial practice, hearings, and out-of-court resolution of both actions and applications before the Federal Court of Canada.
Mr. Guerreiro's work often focuses on building a scientific case and its presentation through expert and fact witnesses. He has also carried substantial responsibility for conducting and supervising complex legal research on a range of topics, and is frequently involved in developing case strategy concerning patent infringement and validity issues under both the "Old" and "New" versions of the Patent Act. In litigation under the Patented Medicines (Notice of Compliance) Regulations, Mr. Guerreiro has experience with both prohibition applications and section 8 damages actions.
In addition, Mr. Guerreiro regularly provides analysis and opinions regarding patent and drug regulatory law compliance and reform, particularly regarding the Patented Medicine Prices Review Board.
- Osgoode Hall Law School Silver Medallist
- McCarthy Tétrault LLP Prize for the student standing second in first year
- Christopher Robinson Prize for the student who takes second place in the examinations of the final year
- Blake, Cassels & Graydon Prize in Business Associations
- Gurston Allen Prize in Conflict of Laws
- Aird & Berlis Prize in Contracts
- McMillan LLP Prize in Contracts
- Harry R. Rose Criminal Law Prize
- Kenneth Gibson Morden Memorial Prize in Evidence
- Cassels Brock & Blackwell Prize in Legal Process
- Canadian Bar Association
- Ontario Bar Association
- Toronto Intellectual Property Group
- The Advocates’ Society
Publication | November 2018
Pharma in brief - Federal Court of Appeal revisits obviousness: guidance provided on “inventive concept” and “obvious to try” test
Publication | April 2017
Publication | October 02, 2019
IP monitor - Derailed on obviousness: Court of Appeal reminds us the characteristics of the skilled worker and common general knowledge are key
Publication | August 08, 2019